Title |
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
|
---|---|
Published in |
BMC Gastroenterology, April 2013
|
DOI | 10.1186/1471-230x-13-67 |
Pubmed ID | |
Authors |
Chaofeng Yang, Weiqin Lu, Tao Lin, Pan You, Min Ye, Yanqing Huang, Xianhan Jiang, Cong Wang, Fen Wang, Mong-Hong Lee, Sai-Ching J Yeung, Randy L Johnson, Chongjuan Wei, Robert Y Tsai, Marsha L Frazier, Wallace L McKeehan, Yongde Luo |
Abstract |
FGF21 is a promising intervention therapy for metabolic diseases as fatty liver, obesity and diabetes. Recent results suggest that FGF21 is highly expressed in hepatocytes under metabolic stress caused by starvation, hepatosteatosis, obesity and diabetes. Hepatic FGF21 elicits metabolic benefits by targeting adipocytes of the peripheral adipose tissue through the transmembrane FGFR1-KLB complex. Ablation of adipose FGFR1 resulted in increased hepatosteatosis under starvation conditions and abrogation of the anti-obesogenic action of FGF21. These results indicate that FGF21 may be a stress responsive hepatokine that targets adipocytes and adipose tissue for alleviating the damaging effects of stress on the liver. However, it is unclear whether hepatic induction of FGF21 is limited to only metabolic stress, or to a more general hepatic stress resulting from liver pathogenesis and injury. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | <1% |
Denmark | 1 | <1% |
Spain | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Unknown | 109 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 16% |
Student > Ph. D. Student | 17 | 15% |
Student > Bachelor | 16 | 14% |
Researcher | 13 | 11% |
Student > Postgraduate | 7 | 6% |
Other | 25 | 22% |
Unknown | 18 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 32 | 28% |
Medicine and Dentistry | 25 | 22% |
Biochemistry, Genetics and Molecular Biology | 21 | 18% |
Immunology and Microbiology | 4 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 6 | 5% |
Unknown | 23 | 20% |